Kaken Pharmaceutical Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KKPCF research report →
Price Chart
About the company
Kaken Pharmaceutical Co. , Ltd. is involved in the development, manufacturing, and commercialization of a diverse range of medical goods, health devices, and agricultural chemicals, serving both domestic and global markets.
- CEO
- Hiroyuki Horiuchi
- IPO
- 2020
- Employees
- 1,114
- HQ
- Tokyo, TY, JP
Get TickerSpark's AI analysis on KKPCF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $984.57M
- P/E
- 15.74
- Fwd P/E
- 0.15
- PEG
- -0.00
- P/S
- 1.67
- P/B
- 0.94
- EV/EBITDA
- 6.29
- Div Yield
- 4.99%
- Gross Margin
- 56.92%
- Op Margin
- 10.48%
- Net Margin
- 10.58%
- ROE
- 6.11%
- ROIC
- 4.28%
Latest fiscal year · YoY change
- Revenue
- $77.35B-17.7%
- Gross Profit
- $39.49B-32.5%
- Op Income
- $-904,658,701
- Net Income
- $2.16B-84.5%
- EPS
- $57.52-84.3%
- OCF Growth
- -137.4%
- FCF Growth
- -155.8%
- 52W High
- $28.12
- 52W Low
- $22.30
- 50D MA
- $26.00
- 200D MA
- $26.00
- Beta
- 0.13
- RSI (14)
- 61
- Avg Volume
- 1
No earnings-call transcripts are available for KKPCF yet.
- Free Float
- 65.8%
- Shares Outstanding
- 37.87M
- Float Shares
- 24.93M
Our KKPCF coverage
Recent articles, reports, and earnings notes.
No research on KKPCF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KKPCF report →